EBV-associated haematologic neoplasms

Clinical trials for EBV-associated haematologic neoplasms explained in plain language.

Never miss a new study

Get alerted when new EBV-associated haematologic neoplasms trials appear

Sign up with your email to follow new studies for EBV-associated haematologic neoplasms, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New cell therapy takes on virus-driven blood cancers in tiny early trial

Disease control By invitation only

This early study tests a new treatment called KSD-101 in 9 adults with blood cancers linked to the Epstein-Barr virus. The main goal is to find a safe dose and see if it shrinks tumors. Participants must have tried standard treatments without success.

Matched conditions: EBV-ASSOCIATED HAEMATOLOGIC NEOPLASMS

Phase 1 • Sponsor: Tongji Hospital • Aim: Disease control

Last updated Jun 27, 2026 12:05 UTC

EBV-associated haematologic neoplasms

Get alerted when new EBV-associated haematologic neoplasms trials appear

New cell therapy takes on virus-driven blood cancers in tiny early trial